MedPath
FDA Approval

NOXAFIL

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
October 20, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Posaconazole(40 mg in 1 mL)

Products4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NOXAFIL

Product Details

NDC Product Code
0085-1328
Application Number
NDA022003
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
October 20, 2023
Code: 6TK1G07BHZClass: ACTIBQuantity: 40 mg in 1 mL
polysorbate 80Inactive
Code: 6OZP39ZG8HClass: IACT
sodium benzoateInactive
Code: OJ245FE5EUClass: IACT
trisodium citrate dihydrateInactive
Code: B22547B95KClass: IACT
citric acid monohydrateInactive
Code: 2968PHW8QPClass: IACT
glycerinInactive
Code: PDC6A3C0OXClass: IACT
xanthan gumInactive
Code: TTV12P4NEEClass: IACT
anhydrous dextroseInactive
Code: 5SL0G7R0OKClass: IACT
titanium dioxideInactive
Code: 15FIX9V2JPClass: IACT
waterInactive
Code: 059QF0KO0RClass: IACT

NOXAFIL

Product Details

NDC Product Code
0085-4324
Application Number
NDA205053
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
October 20, 2023
HYPROMELLOSE ACETATE SUCCINATE 06081224 (3 MM2/S)Inactive
Code: 6N003M473WClass: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671PClass: IACT
POLYETHYLENE GLYCOL 3350Inactive
Code: G2M7P15E5PClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRTClass: IACT
Code: 6TK1G07BHZClass: ACTIBQuantity: 100 mg in 1 1

NOXAFIL

Product Details

NDC Product Code
0085-2224
Application Number
NDA214770
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
October 20, 2023
PROPYLPARABENInactive
Code: Z8IX2SC1OHClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Code: 593YOG76RNClass: IACT
XANTHAN GUMInactive
Code: TTV12P4NEEClass: IACT
SODIUM PHOSPHATE, TRIBASIC, ANHYDROUSInactive
Code: SX01TZO3QZClass: IACT
Code: 6TK1G07BHZClass: ACTIBQuantity: 300 mg in 1 1
HYPROMELLOSE ACETATE SUCCINATE 06081224 (3 MM2/S)Inactive
Code: 6N003M473WClass: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
DIMETHICONEInactive
Code: 92RU3N3Y1OClass: IACT
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIEDInactive
Code: K679OBS311Class: IACT
CARRAGEENANInactive
Code: 5C69YCD2YJClass: IACT
GLYCERINInactive
Code: PDC6A3C0OXClass: IACT
METHYLPARABENInactive
Code: A2I8C7HI9TClass: IACT
SODIUM CITRATE, UNSPECIFIED FORMInactive
Code: 1Q73Q2JULRClass: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TYClass: IACT
SORBITOL SOLUTIONInactive
Code: 8KW3E207O2Class: IACT
CALCIUM SULFATE, UNSPECIFIED FORMInactive
Code: WAT0DDB505Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
POTASSIUM SORBATEInactive
Code: 1VPU26JZZ4Class: IACT

NOXAFIL

Product Details

NDC Product Code
0085-4331
Application Number
NDA205596
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
October 20, 2023
BETADEX SULFOBUTYL ETHER SODIUMInactive
Code: 2PP9364507Class: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT
Code: 6TK1G07BHZClass: ACTIBQuantity: 18 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath